Microbix Biosystems Inc (MBX_TSE)
MBX_TSE moved a median of 0.00% 30 minutes after news, and -1.28% by the close. How MBX_TSE actually reacts to news — the realized, point-in-time move the market made, measured across 89 labeled events over the last three years with zero look-ahead.
MBX_TSE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 21% | 28 |
| 30-min | 0.00% | 32% | 28 |
| 60-min | 0.00% | 36% | 28 |
| to close | -1.28% | 32% | 28 |
| Middle 50% of MBX_TSE reactions | 0.00% to +1.34% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 89 |
Half of all Microbix Biosystems Inc news events land between +0.00% and +1.34% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when MBX_TSE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MBX_TSE's baseline. Nothing else.
Recent MBX_TSE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Microbix Making Keynote Presentation at Masters Summit 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Presenting at Cantech Investment Conference | Press release | ACCESS Newswire | — | — | |
| Microbix Presenting at Muskoka Capital Event | Press release | ACCESS Newswire | — | — | |
| Microbix Qualifies as Supplier for Five Major Dx Test-Makers Product Lines for Support of Leading IVD Manufacturers | Press release | ACCESS Newswire | — | — | |
| Microbix Reports Results for Q3 Fiscal 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Schedules Release of Results for Q3 Fiscal 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Reports Results for H1 & Q2 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Schedules Release of Results for Q2 Fiscal 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Product Results Being Presented at 2026 PASCV | Press release | ACCESS Newswire | — | — | |
| Microbix Engages with Diagnostics Industry Experts | Press release | ACCESS Newswire | — | — | |
| Microbix Presenting at the 2026 Bloom Burton Conference | Press release | ACCESS Newswire | — | — | |
| Microbix Exhibiting & Presenting at ESCMID Global 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Announces Annual Meeting Voting Results | Press release | ACCESS Newswire | — | — | |
| Microbix Presents Reference-Material Innovations at EUROGIN | Press release | ACCESS Newswire | — | — | |
| Microbix's Clot-Buster Drug Project Advances | Press release | ACCESS Newswire | — | — | |
| Microbix Announces Issuance of Stock Options | Press release | ACCESS Newswire | — | — | |
| Microbix Reports Results for Q1 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs | Press release | ACCESS Newswire | — | — | |
| Microbix Schedules Release of Results for Q1 Fiscal 2026 | Press release | ACCESS Newswire | — | — | |
| Microbix Presents Molecular Pathology Platform Results | Press release | ACCESS Newswire | — | — | |
| Microbix Updates Investor Presentation on its Website | Press release | ACCESS Newswire | — | — | |
| Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing | Press release | ACCESS Newswire | — | — | |
| Microbix Reports Results for Q4 and Fiscal 2025 | Press release | GlobeNewswire | — | — | |
| Microbix Schedules Release of Results for Q4 Fiscal 2025 | Press release | GlobeNewswire | — | — | |
| Microbix Launches New Products to Support H3N2 Flu Testing | Press release | GlobeNewswire | — | — | |
| Microbix Announces Initiation of Normal Course Issuer Bid | Press release | GlobeNewswire | — | — | |
| Microbix & Seegene Mexico Collaborate to Improve Test Accuracy | Press release | GlobeNewswire | — | — | |
| Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests | Press release | GlobeNewswire | — | — | |
| Microbix Addresses Cybersecurity Incident | Press release | GlobeNewswire | — | — | |
| Microbix Presenting at Muskoka Capital Event | Press release | GlobeNewswire | — | — | |
| Microbix Assisting EMQN with Second Genetic-Test EQA Program | Press release | GlobeNewswire | — | — | |
| Microbix Client Labquality Introduces Novel EQA Scheme at ESCV | Press release | GlobeNewswire | — | — | |
| Microbix Hosts Ontario Minister Stephen Crawford | Press release | GlobeNewswire | — | — | |
| Microbix Reports Results for Q3 Fiscal 2025 | Press release | GlobeNewswire | — | — | |
| Microbix Schedules Release of Results for Q3 Fiscal 2025 Results Release and Webinar Discussion on Morning of August 14, 2025 | Press release | GlobeNewswire | — | — | |
| Microbix Launches QUANTDx™ Characterized Reference Materials | Press release | GlobeNewswire | — | — | |
| Microbix Exhibiting & Presenting at ADLM | Press release | GlobeNewswire | — | — | |
| Microbix & Bulgaria’s NCIPD Execute Supply Agreement | Press release | GlobeNewswire | — | — | |
| Microbix Attending & Presenting at Asia Pacific POC 2025 | Press release | GlobeNewswire | — | — | |
| Microbix Reports Results for Q2 Fiscal 2025 | Press release | GlobeNewswire | — | — | |
| Microbix & Aurevia Introduce Novel EQA Scheme | Press release | GlobeNewswire | — | — | |
| Microbix Schedules Release of Results for Q2 Fiscal 2025 | Press release | GlobeNewswire | — | — | |
| Microbix’s Clot-Buster Drug Project Advances | Press release | GlobeNewswire | — | — | |
| Microbix Presenting at the 2025 Bloom Burton Conference | Press release | GlobeNewswire | — | — | |
| Microbix Exhibiting at ESCMID Global 2025 | Press release | GlobeNewswire | — | — | |
| Microbix Provides Business Updates | Press release | GlobeNewswire | — | — | |
| Microbix Announces Annual and Special Meeting Voting Results | Press release | GlobeNewswire | — | — | |
| Microbix Further Optimizes Capital Usage and Availability | Press release | GlobeNewswire | — | — | |
| Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific | Press release | GlobeNewswire | — | — | |
| Microbix Hosts Ontario Premier Doug Ford & Team | Press release | GlobeNewswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MBX_TSE section they belong to.
Where else MBX_TSE is measured.
MBX_TSE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CV SCIENCES INC (CVSI) | 90 | +0.59% | 53% |
| Acasti Pharma, Inc. (ACST) | 89 | 0.00% | 44% |
| VIVOS INC (RDGL) | 88 | 0.00% | 43% |
| AMBU A S UNSP/ADR (AMBBY) | 87 | 0.00% | 13% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Microbix Biosystems Inc's median reaction calculated?
Every labeled MBX_TSE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 89 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 32% of MBX_TSE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MBX_TSE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.